1. Pangal A., Shaikh J. A., and Khan E. M. (2017) Current developments of C3-substituted coumarin hybrids as anti-cancer agents. Int. J. Pharm. Sci. Rev. Res., 42 (1), 161-168.
2. Jain P. K., and Joshi H. (2012) Coumarin: Chemical and pharmacological profile. J. Appl. Pharm. Sci., 02 (06), 236-240.
3. Batra N., Batra S., Pareek A., and Nagori B. P. (2012) Diverse pharmacological activities of 3-substituted coumarins: A review. Int. Res. J. of Pharma., 3 (7), 24-29.
4. Pangal A., Gazge M., Mane V., and Shaikh J. A. (2013) Various pharmacological aspects of coumarin derivatives: A review. IJPRBS., 2 (6), 168-194.
5. Shridhar R., Sastry, Reddy C. V., Vaidya N. K., Moorty S. R., Reddy G. S., and Thapar G. S. (1978) Antimicrobial agents: Synthesis and antibacterial activity of some new 4-[2-( heteroaryl) vinyl]coumarins. Ind. J. Chem., 16B, 704-708.
6. Gadaginmath, Guru S., Joshi, and Raghvendra G. (1995) Synthesis and antimicrobial activity of benimidazolyl / coumarinylmethoxyindoles. Ind. J. Chem., 34B, 120-124.
7. Olayinka O. A., and Nwinyi O. C. (2010) Microwave-assisted synthesis and evaluation of antimicrobial activity of 3-{3-(s-aryl and s-heteroaromatic)acryloyl}-2hchromen-2-one derivatives. J. Heterocyclic Chem., 47, 179-187.
8. Rajeshwar R. V., Srimanth K., and Kumar V. P. (2004) Synthesis of 3-[3-substituted thio]-7H-1,2,4-triazolo[3,4-b][1,3,4]thiadiazin-6-yl]-2H-1-benzopyran-2-ones and 3-[3-aminoaryl/heterocyclyl]-7H-1,2,4-triazolo[3,4-b][1,3,4]thiadiazin-6-yl]-2H-1-benzopyran-2-ones. Ind. J. Heter. Chem., 14, 141-144.
9. Srivastav V. K., Tiwari M., Zhang X., and Yao X-J (2018) Synthesis and antiretroviral activity of 6-acetyl-coumarin derivatives against HIV-1 infection. Ind. J. Pharm. Sci., 80 (1), 108-117.
10. Bubols G. B., Vianna D. R., Medina-Remon A., von Poser G., Lamuela-Raventos R. M., Eifler-Lima V. L., and Garcia S. C. (2013) The antioxidant activity of coumarins and flavonoids. Mini Rev. Med. Chem., 13 (3), 318-334.
11. Lin C. L., Hsiao G., Wang C. C., and Lee Y. L. (2016) Imperatorin exerts antiallergic effects in Th2-mediated allergic asthma via induction of IL-10-producing regulatory T cells by modulating the function of dendritic cells. Pharmacol. Res., 110, 111-121.
12. Klenkar J., and Molnar M. (2015) Natural and synthetic coumarins as potential anticancer agents. J. Chem. & Pharma. Res., 7 (7), 1223-1238.
13. Zhang Y., Zhang Q., Song J., Zhang L., Jiang C., and Zhang H. (2018) Design, Synthesis, and Antiproliferative Evaluation of Novel Coumarin/2-Cyanoacryloyl Hybrids as Apoptosis Inducing Agents by Activation of Caspase-Dependent Pathway. Molecules, 23, 1972-1991.
14. Hassan M. Z., Osman H., Ali M. A., and Ahsan M. J. (2016) Therapeutic potential of coumarins as antiviral agents. Eur. J. Med. Chem., 123, 236-255.
15. Kostova I (2006) Synthetic and natural coumarins as antioxidants. Mini Rev. Med. Chem., 6 (4), 365-374.
16. Wu X. Q., Huang C., Jia Y. M., Song B. A., Li J., and Liu X. H. (2014) Novel coumarin-dihydropyrazole thio-ethanone derivatives: design, synthesis and anticancer activity. Eur. J. Med. Chem., 74, 717-725.
17. Vianna D. R., Hamerski L., Figueiró F., Bernardi A., Visentin L. C., Pires E. N., Teixeira H. F., Salbego C. G., Eifler-Lima V. L., Battastini A. M., von Poser G. L., and Pinto A. C. (2012) Selective cytotoxicity and apoptosis induction in glioma cell lines by 5-oxygenated-6,7-methylenedioxycoumarins from Pterocaulon species. Eur. J. Med. Chem., 57, 268-274.
18. Chen Y., Liu H. R., Liu H. S., Cheng M., Xia P., Qian K., Wu P. C., Lai C. Y., Xia Y., Yang Z. Y., Morris-Natschke S. L., and Lee K. H. (2012) Antitumor agents 292. Design, synthesis and pharmacological study of S- and O-substituted 7-mercapto- or hydroxy-coumarins and chromones as potent cytotoxic agents. Eur. J. Med. Chem., 49, 74-85.
19. Fong W. F., Shen X. L., Globisch C., Wiese M., Chen G. Y., Zhu G. Y., Yu Z. L., Tse A. K., and Hu Y. J. (2008) Methoxylation of 3',4'-aromatic side chains improves P-glycoprotein inhibitory and multidrug resistance reversal activities of 7,8-pyranocoumarin against cancer cells. Bioorg. Med. Chem., 16, 3694-3703.
20. Zhou T., Shi Q, Bastow K. F., and Lee K. H. (2010) Antitumor agents 286. Design, synthesis, and structure-activity relationships of 3'R,4'R-disubstituted-2',2'-dimethyldihydropyrano[2,3-f]chromone (DSP) analogues as potent chemosensitizers to overcome multidrug resistance. J. Med. Chem., 53, 8700-8708.
21. Vázquez R., Riveiro M. E., Vermeulen M., Alonso E., Mondillo C, Facorro G., Piehl L., Gómez N., Moglioni A., Fernández N., Baldi A., Shayo C., and Davio C. (2012) Structure-anti-leukemic activity relationship study of ortho-dihydroxycoumarins in U-937 cells: key role of the δ-lactone ring in determining differentiation-inducing potency and selective pro-apoptotic action. Bioorg. Med. Chem., 20 (18), 5537-5549.
22. Riveiro M. E., De Kimpe N., Moglioni A., Vázquez R., Monczor F., Shayo C., and Davio C. (2010) Coumarins: old compounds with novel promising therapeutic perspectives. Curr. Med. Chem., 17 (13), 1325-1338.
23. Molaverdi F., Khoobi M., Emami S., Alipour M., Firuzi O., Foroumadi A., Dehghan G., Miri R., Shaki F., Jafarpour F., and Shafiee A. (2013) Polyoxygenated cinnamoylcoumarins as conformationally constrained analogs of cytotoxic diarylpentanoids: synthesis and biological activity. Eur. J. Med. Chem., 68, 103-110.
24. Dai H., Huang M., Qian J., Liu J., Meng C., Li Y., Ming G., Zhang T., Wang S., Shi Y., Yao Y., Shushan G., Zhang Y., and Ling Y. (2019) Excellent antitumor and antimetastatic activities based on novel coumarin/pyrazole oxime hybrids. Eur. J. Med. Chem., 166, 470-479.
25. Cho J. H., Shin J., Cho J., Choi Y. H., Shim J. H., and Chae J. (2015) Esculetin (6,7-dihydroxycoumarin): a potential cancer chemopreventive agent through suppression of Sp1 in oral squamous cancer cells. Int. J. Oncol., 46, 265-271.
26. Zhang L., Jiang G., Yao F., He Y., Liang G., Zhang Y., Hu B., Wu Y., Li Y. and Liu H. (2012) Growth inhibition and apoptosis induced by osthole, a natural coumarin in hepatocellular carcinoma. PLoS One., 7 (5), e37865.
27. Chen Y., Liu H. R., Liu H. S., Cheng M., Xia P., Qian K., Wu P. C., Lai C. Y., Xia Y., Yang Z. Y., Morris-Natschke S. L., and Lee K. H. (2012) Antitumor agents 292. Design, synthesis and pharmacological study of S- and O-substituted 7-mercapto- or hydroxy-coumarins and chromones as potent cytotoxic agents. Eur. J. Med. Chem., 49, 74-85.
28. Nasr T., Bondock S., and Youns M. (2014) Anticancer activity of new coumarin substituted hydrazide-hydrazone derivatives. Eur. J. Med. Chem., 76, 539-548.
29. Bisi A., Cappadone C., Rampa A., Farruggia G., Sargenti A., Belluti F., Di Martino R.M.C., Malucelli E., Meluzzi A., Iotti S., and Gobbi S. (2017) Coumarin derivatives as potential antitumor agents: Growth inhibition, apoptosis induction and multidrug resistance reverting activity. Eur. J. Med. Chem., 127, 577-585.
30. Zhang C. (2014) Recent advances in trifluoromethylation of organic compounds using Umemoto’s reagents. Org. Biomol. Chem., 12, 6580-6589.
31. Betageri R., Zhang Y., Zindel R. M., Kuzmich D., Kirrane T. M., Bentzien J., Cardozo M., Capolino A. J., Fadra T. N., Nelson R. M., Paw Z., Shih D. T., Shih C. K., Zuvela-Jelaska L., Nabozny G., and Thomson D.S. (2005) Trifluoromethyl group as a pharmacophore: effect of replacing a -CF3 group on binding and agonist activity of a glucocorticoid receptor ligand. Bioorg. Med. Chem. Lett., 15 (21), 4761-4769.
32. Lu X. Y., Wang Z. C., Ren S. Z., Shen F. Q., Man R. J., and Zhu H. L. (2016) Coumarin sulfonamides derivatives as potent and selective COX-2 inhibitors with efficacy in suppressing cancer proliferation and metastasis. Bioorg. Med. Chem. Lett., 26 (15), 3491-3498.
33. Vichai V. and Kirtikara K. (2006) Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat. Protoc., 1 (3), 1112-1116.
34. Esteban A., Orellana, and Kasinski A. L. (2016) Sulforhodamine B (SRB) Assay in cell culture to investigate cell proliferation. Bio. Protoc., 6 (21), 1984-1993.
35. Rajeswar R. V., and Kumar R. V. (2002) Synthesis of 3-(1-aryl-2-mercaptoimidazolyl)-2H-1-benzopyran-2-one. Ind. J. Chem., 41B, 415–418.
36. George S., Kumaran S., Chandran M., Gangwar P., and Gururagavan M. (2012) Docking studies of novel coumarin derivatives as arylamine N-acetyltransferace 2 inhibitors. Asian J. Pharm. Clin. Res., 5 (1), 94-96.
37. Smith, W. L., Urade Y., and Jakobsson P. J. (2011) Enzymes of the cyclooxygenase pathways of prostanoid biosynthesis. Chem. Rev., 111, 5821-5865.
38. Hashemi G. N., Najafi M., Salehi E., Farhood B., and Mortezaee K. (2019) Cyclooxygenase-2 in cancer: A review. J. Cell Physiol., 234 (5), 5683-5699.
39. Dawood D. H., Batran R. Z., Farghaly T. A., Khedr M. A., and Abdulla M. M. (2015) New Coumarin Derivatives as Potent Selective COX-2 Inhibitors: Synthesis, anti-inflammatory, QSAR, and molecular modeling studies. Arch. Pharm. (Weinheim)., 348 (12), 875-888.
40. Guravaiah N., and Rao R. V. (2011) Efficient, Stereoselective approach to the synthesis of 3-(1-Phenyl-2-(Z-styrylsulfonyl)-1H-imidazol-4-yl)-2H-chromen-2-ones. Synth. Commun., 41 (8), 1167-1174.
41. Skehan P., Storeng R., Scudiero D., Monks A., McMahon J., Vistica D., Warren J. T., Bokesch H., Kenney S., and Boyd M.R. (1990) New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst., 82 (13), 1107-1112.
42. Jenny M., Klieber M., Zaknun D., Schroecksnadel S., Kurz K., Ledochowski M., Schennach H., and Fuchs D. (2011) In vitro testing for anti-inflammatory properties of compounds employing peripheral blood mononuclear cells freshly isolated from healthy donors. Inflamm Res., 60 (2), 127-135.
43. Pangal A., Gazge M., Yusufi M., Devasthale G., and Khan E. (2014) In vitro investigation of antibacterial activity of novel 3-acetylcoumarin schiff bases and their molecular docking studies. Int. J. Pharm. Res. Scholars., 3 (1), 696-703.